MITOCHONDRIAL FUNCTION--AGE, GENDER, AND DISEASE EFFECTS

线粒体功能——年龄、性别和疾病的影响

基本信息

  • 批准号:
    2411404
  • 负责人:
  • 金额:
    $ 7.35万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1997
  • 资助国家:
    美国
  • 起止时间:
    1997-07-15 至 1999-06-30
  • 项目状态:
    已结题

项目摘要

Post-menopausal women have a poorer prognosis after myocardial infarction (MI) than men. Partial explanations for the greater mortality and morbidity in women are loss of beneficial effects of estrogen or gender differences in age, coincident diseases, or treatments. Minimal attention has been given to the plausible alternative explanation that gender influences the basic pathophysiological outcomes of MI, specifically outcomes affected by the cardiac antioxidant defense systems (ADS). ADS provides vital protection against the reactive oxygen species (ROS) that are released during the detrimental ischemia and reperfusion (I/R) events of MI. Mitochondria are a dominant target site of ROS leaked in small amount during normal oxidative phosphorylation and in massive amounts during I/R. Mitochondrial ADS has been reported decreased in the hearts of male rodents by aging. My preliminary research indicates that aging has little effect on cardiac mitochondrial ADS of female rats, and thus provides strong evidence of gender differences in responses of cardiac ADS to aging. Proposed research will test the hypothesis that gender, age and disease are interdependent variables in the vulnerability of cardiac mitochondria to injury by ROS. Hyperthyroidism is the disease for study since it is reported to increase oxidative stress from ROS leakage in association with modified ADS status in cardiac mitochondria of male rats. Further research in my laboratory has indicated that the minimal effects of hyperthyroidism on cardiac mitochondria of female rats may be partially beneficial. AIM 1 will compare the effects of gender and aging On the responses of rat cardiac mitochondria to repeated short ROS insults followed by recovery periods. Experiments will expose cardiac mitochondria to a superoxide generating system and assess consequences of this insult on mitochondrial ADS, respiration, energy yield, and protein/lipid oxidation. AIM 2 will compare the responses of gender and aging on the responses of isolated perfused rat hearts to "stunning" produced by short periods of I/R. Then consequences of this insult on energy status, respiratory function, and indices of peroxidation will be monitored in mitochondria and cytosol. AIM 3 will evaluate the effect of chronic, elevated oxidative stress (e.g., hyperthyroidism) on rat mitochondrial ADS levels in heart, and on the responses of these mitochondria to repeated short ROS insults followed by recovery periods. Information obtained about correlations between ADS status and the vulnerability of cardiac mitochondria to ROS-mediated insults should provide clues to rationale development of better strategies for prevention/treatment of MI in women, especially aged women.
绝经后女性心肌梗死后预后较差 梗塞(MI)的发生率高于男性。对更大的部分的解释 妇女的死亡率和发病率是由于失去了 雌激素或年龄、同时患有疾病的性别差异,或 治疗。对看似合理的情况给予了最低限度的关注 另一种解释是性别影响基本的 MI 的病理生理结果,特别是受以下因素影响的结果 心脏抗氧化防御系统(ADS)。 ADS 提供了至关重要的 防止释放的活性氧 (ROS) 在 MI 的有害缺血和再灌注 (I/R) 事件期间。 线粒体是少量ROS泄漏的主要靶点 在正常的氧化磷酸化过程中和大量的过程中 I/R。 据报道,男性心脏中的线粒体 ADS 减少 啮齿类动物因衰老而死亡。我的初步研究表明,衰老已经 对雌性大鼠心脏线粒体ADS影响不大,因此 提供了心脏反应中性别差异的有力证据 ADS 导致老化。拟议的研究将检验以下假设:性别、 年龄和疾病是影响脆弱性的相互依存的变量 ROS 损伤心脏线粒体。甲亢是一种疾病 用于研究,因为据报道它会增加 ROS 的氧化应激 渗漏与心脏线粒体 ADS 状态改变相关 雄性大鼠。我的实验室的进一步研究表明 甲状腺功能亢进症对女性心肌线粒体的影响极小 老鼠可能是部分有益的。 AIM 1 将比较性别和老龄化对以下人员的反应的影响 大鼠心脏线粒体重复短暂的 ROS 损伤,然后 恢复期。 实验将把心肌线粒体暴露于 超氧化物生成系统并评估这种侮辱的后果 线粒体 ADS、呼吸、能量产量和蛋白质/脂质 氧化。 AIM 2 将比较性别和年龄对反应的反应 短期内产生的离体灌注大鼠心脏“令人震惊” I/R 的。然后这种侮辱对能量状态、呼吸系统的影响 将监测线粒体的功能和过氧化指数 和细胞质。 AIM 3 将评估慢性氧化应激升高的影响 (例如,甲状腺功能亢进症)对大鼠心脏线粒体 ADS 水平的影响,以及 关于这些线粒体对重复短暂的 ROS 损伤的反应 接下来是恢复期。 获得有关 ADS 状态和 心脏线粒体对 ROS 介导的损伤的脆弱性应该 为合理制定更好的战略提供线索 预防/治疗女性尤其是老年女性的心肌梗死。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MARY F KANZ其他文献

MARY F KANZ的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MARY F KANZ', 18)}}的其他基金

Biliary and Intestinal Cell Models of Drug Toxicity
药物毒性的胆道和肠细胞模型
  • 批准号:
    6730605
  • 财政年份:
    2003
  • 资助金额:
    $ 7.35万
  • 项目类别:
Biliary and Intestinal Cell Models of Drug Toxicity
药物毒性的胆道和肠细胞模型
  • 批准号:
    6651899
  • 财政年份:
    2003
  • 资助金额:
    $ 7.35万
  • 项目类别:
METHYLENE DIANILINE--A SELECTIVE BILE DUCT TOXICANT?
亚甲基二苯胺——一种选择性胆管毒物?
  • 批准号:
    2518658
  • 财政年份:
    1995
  • 资助金额:
    $ 7.35万
  • 项目类别:
METHYLENE DIANILINE--A SELECTIVE BILE DUCT TOXICANT?
亚甲基二苯胺——一种选择性胆管毒物?
  • 批准号:
    2155212
  • 财政年份:
    1995
  • 资助金额:
    $ 7.35万
  • 项目类别:
METHYLENE DIANILINE--A SELECTIVE BILE DUCT TOXICANT?
亚甲基二苯胺——一种选择性胆管毒物?
  • 批准号:
    2155211
  • 财政年份:
    1995
  • 资助金额:
    $ 7.35万
  • 项目类别:
MODULATION OF TOXIN INJURY BY HYPO/HYPER THYROIDISM
甲状腺功能减退/亢进对毒素损伤的调节
  • 批准号:
    3465124
  • 财政年份:
    1987
  • 资助金额:
    $ 7.35万
  • 项目类别:
MODULATION OF TOXIN INJURY BY HYPO/HYPER THYROIDISM
甲状腺功能减退/亢进对毒素损伤的调节
  • 批准号:
    3465126
  • 财政年份:
    1987
  • 资助金额:
    $ 7.35万
  • 项目类别:
MODULATION OF TOXIN INJURY BY HYPO/HYPER THYROIDISM
甲状腺功能减退/亢进对毒素损伤的调节
  • 批准号:
    3465125
  • 财政年份:
    1987
  • 资助金额:
    $ 7.35万
  • 项目类别:

相似海外基金

Interplay between Aging and Tubulin Posttranslational Modifications
衰老与微管蛋白翻译后修饰之间的相互作用
  • 批准号:
    24K18114
  • 财政年份:
    2024
  • 资助金额:
    $ 7.35万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The Canadian Brain Health and Cognitive Impairment in Aging Knowledge Mobilization Hub: Sharing Stories of Research
加拿大大脑健康和老龄化认知障碍知识动员中心:分享研究故事
  • 批准号:
    498288
  • 财政年份:
    2024
  • 资助金额:
    $ 7.35万
  • 项目类别:
    Operating Grants
EMNANDI: Advanced Characterisation and Aging of Compostable Bioplastics for Automotive Applications
EMNANDI:汽车应用可堆肥生物塑料的高级表征和老化
  • 批准号:
    10089306
  • 财政年份:
    2024
  • 资助金额:
    $ 7.35万
  • 项目类别:
    Collaborative R&D
関節リウマチ患者のSuccessful Agingに向けたフレイル予防対策の構築
类风湿性关节炎患者成功老龄化的衰弱预防措施的建立
  • 批准号:
    23K20339
  • 财政年份:
    2024
  • 资助金额:
    $ 7.35万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Baycrest Academy for Research and Education Summer Program in Aging (SPA): Strengthening research competencies, cultivating empathy, building interprofessional networks and skills, and fostering innovation among the next generation of healthcare workers t
Baycrest Academy for Research and Education Summer Program in Aging (SPA):加强研究能力,培养同理心,建立跨专业网络和技能,并促进下一代医疗保健工作者的创新
  • 批准号:
    498310
  • 财政年份:
    2024
  • 资助金额:
    $ 7.35万
  • 项目类别:
    Operating Grants
Life course pathways in healthy aging and wellbeing
健康老龄化和福祉的生命历程路径
  • 批准号:
    2740736
  • 财政年份:
    2024
  • 资助金额:
    $ 7.35万
  • 项目类别:
    Studentship
I-Corps: Aging in Place with Artificial Intelligence-Powered Augmented Reality
I-Corps:利用人工智能驱动的增强现实实现原地老龄化
  • 批准号:
    2406592
  • 财政年份:
    2024
  • 资助金额:
    $ 7.35万
  • 项目类别:
    Standard Grant
NSF PRFB FY 2023: Connecting physiological and cellular aging to individual quality in a long-lived free-living mammal.
NSF PRFB 2023 财年:将生理和细胞衰老与长寿自由生活哺乳动物的个体质量联系起来。
  • 批准号:
    2305890
  • 财政年份:
    2024
  • 资助金额:
    $ 7.35万
  • 项目类别:
    Fellowship Award
虚弱高齢者のSuccessful Agingを支える地域課題分析指標と手法の確立
建立区域问题分析指标和方法,支持体弱老年人成功老龄化
  • 批准号:
    23K20355
  • 财政年份:
    2024
  • 资助金额:
    $ 7.35万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
「ケア期間」に着目したbiological aging指標の開発
开发聚焦“护理期”的生物衰老指数
  • 批准号:
    23K24782
  • 财政年份:
    2024
  • 资助金额:
    $ 7.35万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了